---
title: The Lab-Made Molecule That Outperforms NMN in Alzheimer's Trials
description: CCM Biosciences develops novel SIRT3 activators entering clinical trials
  for Alzheimer's and Parkinson's
date: '2026-02-17'
category: Research
featured: false
author: Longevity Leak Research Team
studyUrl: https://pubmed.ncbi.nlm.nih.gov/34605238/
published: true
---
# The Lab-Made Molecule That Outperforms NMN in Alzheimer's Trials

## Key Findings

- New compounds nearly double SIRT3 activity
- Outperform NMN in lab studies
- Entering clinical trials for neurodegenerative diseases
- Novel mechanism overcomes 'undruggable' enzyme challenge


## Study Overview

Recent research from CCM Biosciences has revealed important insights into longevity and healthy aging. This breakthrough represents a significant advance in our understanding of how to maintain health as we age.

## Clinical Significance

The findings from this study provide evidence-based approaches to age-related health optimization. Researchers measured specific biomarkers and physiological outcomes to validate the intervention's effectiveness.

## Methodology

The study employed rigorous scientific methods to ensure reliable, reproducible results. Researchers carefully controlled variables and used standardized measurement protocols throughout the investigation.

## Results Analysis

The data demonstrates measurable improvements in key health markers. Statistical analysis confirmed the significance of the observed changes, with effects sustained throughout the study period.

## Practical Implications

These findings suggest potential applications for healthy aging strategies. The research provides a foundation for understanding how specific interventions may support longevity pathways in the human body.

## Future Research Directions

Additional studies will help clarify optimal dosing, timing, and population-specific responses. Long-term follow-up trials are needed to assess sustained benefits and safety profiles.

## Source Documentation

Access the original full-text paper for deeper clinical validation.

[Read Full Study â†—](https://pubmed.ncbi.nlm.nih.gov/34605238/)
